Deep Track Capital, LP - 08 Jan 2026 SCHEDULE 13G Report for Century Therapeutics, Inc. Common Stock, par value $0.0001 per share (IPSC)

Filing Manager
Deep Track Capital, LP
Reporting Manager
Deep Track Capital, LP
Security
Century Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol
IPSC
Shares outstanding
183,738,420 shares
Disclosed Ownership
13,486,400 shares
Ownership
7.3%
Form type
SCHEDULE 13G
Filing time
15 Jan 2026, 16:13:45 UTC
Date of event
08 Jan 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Deep Track Capital, LP disclosed 7.3% ownership in Century Therapeutics, Inc. Common Stock, par value $0.0001 per share (IPSC) on 08 Jan 2026."

Quick Takeaways

  • Deep Track Capital, LP filed SCHEDULE 13G for Century Therapeutics, Inc. Common Stock, par value $0.0001 per share (IPSC).
  • Disclosed ownership: 7.3%.
  • Date of event: 08 Jan 2026.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 15 Jan 2026, 16:13.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deep Track Capital, LP 7.3% 13,486,400 0 13,486,400 /s/ David Kroin David Kroin, Managing Member of the General Partner of the Investment Adviser
Deep Track Biotechnology Master Fund, Ltd. 5.8% 10,609,008 0 10,609,008 /s/ David Kroin David Kroin, Director
David Kroin 7.3% 13,486,400 0 13,486,400 /s/ David Kroin David Kroin
Deep Track Special Opportunities Fund, LP. 1.6% 2,877,392 0 2,877,392 /s/ David Kroin David Kroin, Managing Member of the General Partner of the Investment Adviser of Deep Track Special Opportunities Fund, LP

Sponsored